BiotechTube
Home/Advesya/Jens Hasskarl
JH

Jens Hasskarl

Chief Medical Officer

Advesya

Therapeutic Areas

OncologyAutoimmune Diseases

Advesya Pipeline

DrugIndicationPhase
ADV-101Oncology (e.g., Esophageal Cancer)Phase 1
CCTx-001Oncology (likely), Autoimmune (potential)Phase 1

Leadership Team at Advesya

KP
Ksenija Pavletic
Chief Executive Officer, Board Member
ER
Erik Rutjens
Chief Technology Officer
RC
Richard C. A. Sainson
Chief Scientific Officer
TG
Thomas Gidoin
Chief Financial Officer
DC
Dr. Christophe Ferrand
Academic Founder, Board Member
DM
Dr. Marina Deschamps
Academic Founder
View full Advesya profile